Lentiviral-Mediated Knock-Down of Human HPIP Inhibits Cell Growth and Proliferation

XU Xiao-Jie,FAN Zhong-Yi,HAN Yong-Jian,ZHANG Hao,DING Li-Hua,HAN Ju-Qiang,WANG Ling-Xue,YANG Zhi-hong,DU Nan,YE Qi-Nong
DOI: https://doi.org/10.3969/j.issn.1009-0002.2011.03.004
2011-01-01
Abstract:Objective:To establish an efficient and stable way to deliver hematopoietic PBX-interacting protein(HPIP) small interfering RNA(siRNA) and examine the effect of HPIP siRNA on cell proliferation.Methods:pLenti-H1/HPIP siRNA was constructed and transfected into 293T cells.Western blot and real-time RT-PCR were carried out to detect the inhibitory effect of Lenti-H1 HPIP siRNA.The four viral packaging vectors together with pLenti-H1/HPIP siRNA were used to transfect 293T cells to produce lentivirus particles.After HeLa and HepG2 cells were infected with the obtained viruses and screened for 2 weeks with puromicin,the expression of HPIP was examined by Western blot analysis.Crystal violet assay was performed to investigate the effect of lentivirus on tumor growth and proliferation.Results:Western blot and real-time RT-PCR showed that pLenti-H1/HPIP siRNA could suppress the expression level of HPIP.Crystal violet analysis showed that down-regulation of HPIP could obviously suppress cell growth and proliferation.Conclusion:pLenti-H1/HPIP siRNA can significantly inhibit the expression of HPIP and suppress cell growth and proliferation.HPIP might serve as a novel target for cancer therapy.
What problem does this paper attempt to address?